These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2934640)

  • 21. Beta-endorphin-induced decrease in hypothalamic dopamine turnover.
    van Loon GR; Ho D; Kim C
    Endocrinology; 1980 Jan; 106(1):76-80. PubMed ID: 7349975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of prostaglandin E2 on ACTH and beta-endorphin release from rat adenohypophysis in vitro after secretagogues which can mimic various first or second messengers.
    Knepel W; Götz D
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):149-55. PubMed ID: 3018594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor.
    Vlaskovska M; Hertting G; Knepel W
    Endocrinology; 1984 Sep; 115(3):895-903. PubMed ID: 6204854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermoregulatory (core, surface and metabolic) responses of unrestrained rats to repeated POAH injections of beta-endorphin or adrenocorticotropin.
    Thornhill JA; Saunders WS
    Peptides; 1984; 5(4):713-9. PubMed ID: 6093074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of neuropeptides on discrete-trial conditioned avoidance responding.
    Luttinger D; Nemeroff CB; Prange AJ
    Brain Res; 1982 Apr; 237(1):183-92. PubMed ID: 6176291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of prostaglandin E2 and beta-endorphin-like immunoreactivity from rat adenohypophysis in vitro: variations after adrenalectomy or lesions of the paraventricular nuclei.
    Knepel W; Vlaskovska M; Meyer DK
    Brain Res; 1985 Feb; 326(1):87-94. PubMed ID: 3155985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats.
    Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K
    Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory and inhibitory effects of prostaglandin E2 on prolactin release in the domestic fowl.
    Hall TR; Harvey S; Chadwick A; Scanes CG
    Gen Comp Endocrinol; 1984 Dec; 56(3):368-75. PubMed ID: 6439599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of lordosis behaviour in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area.
    Sirinathsinghji DJ
    Brain Res; 1986 Jun; 375(1):49-56. PubMed ID: 3013371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat.
    Szafarczyk A; Malaval F; Laurent A; Gibaud R; Assenmacher I
    Endocrinology; 1987 Sep; 121(3):883-92. PubMed ID: 3040380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ambient temperature modulates the differentiated cardiorespiratory pattern generated by the central noradrenergic system, most likely via alterations of thyrotropin-releasing hormone (TRH) activity.
    Riedel W
    J Auton Nerv Syst; 1985; 12(2-3):145-57. PubMed ID: 3923090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. beta-Endorphin alters dopamine uptake by the dopamine neurons of the hypothalamus and striatum.
    George SR; Van Loon GR
    Brain Res; 1982 Sep; 248(2):293-303. PubMed ID: 6291701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of beta-endorphin on catecholamine levels in the rat hypothalamus and cerebral cortex].
    Slavnov VN; Valueva GV; Markov VV; Luchitskiĭ EV
    Biull Eksp Biol Med; 1986 May; 101(5):562-4. PubMed ID: 2939890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurotransmitter effects on body temperature are modified with increasing age.
    Ferguson AV; Turner SL; Cooper KE; Veale WL
    Physiol Behav; 1985 Jun; 34(6):977-81. PubMed ID: 2865762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further evidence for a physiological role for hypothalamic dopamine in thermoregulation in the rat.
    Cox B; Lee TF
    J Physiol; 1980 Mar; 300():7-17. PubMed ID: 7381796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperthermia and antinociceptive activity of thyrotropin-releasing hormone and morphine following central administration in rats.
    Zhukov VN; Yakimova KS; Shamyakina IY
    Acta Physiol Pharmacol Bulg; 1988; 14(2):18-23. PubMed ID: 3146885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release.
    Brunetti L; Orlando G; Michelotto B; Recinella L; Vacca M
    Eur J Pharmacol; 2000 Dec; 409(2):103-7. PubMed ID: 11104823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 39. Lateral cerebral ventricle and preoptic-anterior hypothalamic area infusion and perfusion of beta-endorphin and ACTH to unrestrained rats: core and surface temperature responses.
    Thornhill JA; Wilfong A
    Can J Physiol Pharmacol; 1982 Oct; 60(10):1267-74. PubMed ID: 6293691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of thyrotropin-releasing hormone and cyclo-histidine-proline on the homeothermic development of neonatal rats.
    Sato T; Kato T; Miyamori C; Kajiwara S; Murata A; Imura E; Sakura N; Hashimoto T
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):181-8. PubMed ID: 3096034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.